Pharmacokinetics of tamsulosin in subjects with normal and varying degrees of impaired renal function: an open-label single-dose and multiple-dose study

Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level-time curve

Win L. Chiou · Journal of Pharmacokinetics and Biopharmaceutics · 1978 · 623 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +14

Increased Plasma Protein Binding of Propranolol and Chlorpromazine Mediated by Disease-Induced Elevations of Plasma α₁Acid Glycoprotein

Kenneth M. Piafsky, Ingegerd Odar‐Cederlöf, C. Johansson et al. · New England Journal of Medicine · 1978 · 293 citations

Medicine, Clinical Pharmacokinetics, Pharmacology +15

Tamsulosin, the first prostate-selective alpha 1A-adrenoceptor antagonist. A meta-analysis of two randomized, placebo-controlled, multicentre studies in patients with benign prostatic obstruction (symptomatic BPH). European Tamsulosin Study Group.

Christopher R. Chapple, J J Wyndaele, J. Nørdling et al. · PubMed · 1996 · 219 citations

Medicine, Pharmacology, Urology +13

Comparison of tamsulosin with alfuzosin in the treatment of patients with lower urinary tract symptoms suggestive of bladder outlet obstruction (symptomatic benign prostatic hyperplasia)

J M Buzelin, E. Fonteyne, M Kontturi et al. · British Journal of Urology · 1997 · 152 citations · Full text

Medicine, Pharmacotherapy, Urology +13

Clinical comparison of selective and non‐selective &agr; ₁ A‐adrenoreceptor antagonists in benign prostatic hyperplasia: studies on tamsulosin in a fixed dose and terazosin in increasing doses

E. LEE, Changhyoup Lee · British Journal of Urology · 1997 · 140 citations

Medicine, Pharmacotherapy, Urology +14